Type 2 diabetes
Conditions
Interventions
None listed
Sponsors
Kumamoto University
Department of Gastroenterology, The University of Tokyo Hospital Department of Diabetes and Metabolic Diseases, The University of Tokyo Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects with type 2 diabetes who has non-B or non-C hepatocellular cancer and were followed by specialists of diabetes for at least 5 years were enrolled in this study. Moreover, subjects with diabetes who were enrolled in the "Okanoue study designed from Ministry of Health, Labour and Welfare: The observational study of NASH for the clarification of clinical states, diagnostic procedure and novel therapeutics."
Exclusion criteria
Exclusion criteria: 1) Subjects who were diagnosed as hepatocellular carcinoma at the age of 25 or less. 2) Subjects who were diagnosed as chronic hepatitis B or chronic hepatitis C. 3) Subjects who were not sutbable to enroll the study by physician in charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of several data showed below between HCC-developed and HCC-undeveloped type 2 diabetic patients. 1) gender, age, BMI, abdominal circumference, maximum body weight, treatment of diabetes, hypertension and dislipidemia, history of alcohol 2) blood examination: number of Plates 3) Blood chemistry: Albumin, AST, ALT, T-bil, BUN, s-Cre, GGT, ALP, T-Chol, TG, HDL-C, UA, blood glucose level, HbA1c, glicoalbumin 4) coagulation: prothrombin time | — |
Countries
Japan
Contacts
Public ContactTakeshi Matsumura
Kumamoto University Hospital Diabetes, Metabolism and Endocrinology
Outcome results
None listed